BW Investors Have Opportunity to Lead Babcock & Wilcox Enterprises, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Babcock & Wilcox Enterprises, Inc. (“B&W” or “the Company”) (
NYSE: BW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
PCBB Appoints Matt Wallace as EVP & Chief Information OfficerVeteran banking technology leader enabling faster payments and new digital solutions for community financial institutions
STLA Investors Have Opportunity to Lead Stellantis N.V. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Stellantis N.V. (“Stellantis” or “the Company”) (
NYSE: STLA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
DOL and IRS Enforcement Intensifies: Why Employee Benefit Plan Audit Quality Is Now a Fiduciary RiskNew Data Shows Nearly One in Three Employee Benefit Plan Audits Contain Major Deficiencies, Elevating Exposure for Plan Sponsors
Intermountain Health Primary Children’s Hospital in Lehi, Utah is Already ExpandingJust Two Years After Opening, Intermountain Health Primary Children’s Hospital - Miller Family Campus in Lehi is Already Expanding to Meet Growing Demand for Pediatric Care
Exail Technologies to Present at the AI & Tech Virtual Investor Conference April 23rdCompany invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
UPST Investors Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Upstart Holdings, Inc. (“Upstart” or “the Company”) (
NASDAQ: UPST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NFTE Announces 2025-2026 World Series of Innovation Impact League WinnersYoung innovators from around the globe recognized for solutions advancing the UN Sustainable Development Goals
Top Trends for Swoon-Worthy Cruise VacationsNEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- (Feature Impact) From immersive dining to wellness at sea and elevated entertainment, cruise vacations are becoming some of the most experience-rich trips travelers can take.
NUAI Investors Have Opportunity to Lead New Era Energy & Digital, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against New Era Energy & Digital, Inc. (“New Era” or “the Company”) (
NASDAQ: NUAI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. (“Medpace” or “the Company”) (
NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Becoming Independent Named No. 17 on “The NonProfit Times' 2026 Best Nonprofits To Work For”Santa Rosa Nonprofit Earns National Recognition for Exceptional Workplace Culture and Employee Experience
Airia Shortlisted in The 2026 Security AwardsAI control plane recognized for giving enterprises complete visibility, security, and governance over their AI ecosystem
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gossamer Bio, Inc. (“Gossamer” or “the Company”) (
NASDAQ: GOSS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
PINS Investors Have Opportunity to Lead Pinterest, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pinterest, Inc. (“Pinterest” or “the Company”) (
NYSE: PINS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
AcuityTec Expands Device and Payment Intelligence to Strengthen Fraud Detection Across the Customer LifecycleMONTREAL, April 21, 2026 (GLOBE NEWSWIRE) -- AcuityTec, a leader in KYT, transaction monitoring, fraud defense, and KYC compliance, today announced a series of platform enhancements designed to strengthen fraud detection, enhance credit card payment verification intelligence, and give operators greater risk control and visibility across the entire customer lifecycle.
Just Published! A Young Chef's Journey Featuring an Enchanted Prosthetic and a Culinary Mystery Await Young Readers In New ReleaseJoin Owyn and friends on a magical culinary quest as they uncover mysteries and learn valuable lessons, brought to you by Palmetto Publishing.
Record-Breaking SpringFest 2026 Affirms A4M as the Central Forum for Longevity MedicineSurging attendance, standing-room-only sessions, and a packed exhibit hall revealed just how fast longevity medicine is scaling — and where the field is heading next.
ENR FutureTech 2026 Announces Top Speaker Lineup for May 4-6 Return to San Francisco35+ Contractors, Founders, and Investors Converge in San Francisco to Address AI, Reality Capture, and What's Actually Working in the Field
Gradient Deploys Window Heat Pumps at Providence Public Housing Tower, Unlocking 450,000 kWh in Annual SavingsBuilding-wide installation at Carroll Tower marks milestone for Clean Heat Rhode Island program and proves a replicable model for multifamily electrification
Patriot Mobile joins America First Policy Institute for America’s 250th Celebration in Fort Worth, TexasFort Worth, TX, April 21, 2026 (GLOBE NEWSWIRE) -- FORT WORTH, TX — Patriot Mobile, America’s only Christian conservative wireless provider, joins the America First Policy Institute’s America First Freedom 250 Rodeo and Concert in Fort Worth’s iconic Cowtown Coliseum on Thursday, April 30th. This unforgettable evening of patriotism and entertainment will include opportunities benefitting the Special Forces Trust, supporting the nation’s elite warriors and their families.
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Aldeyra Therapeutics, Inc. (“Aldeyra” or “the Company”) (
NASDAQ: ALDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual MeetingCAMBRIDGE, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced multiple presentations at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting from May 29 – June 2, 2026, in Chicago.
VITL Investors Have Opportunity to Lead Vital Farms, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Vital Farms, Inc. (“Vital Farms” or “the Company”) (
NASDAQ: VITL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026Garching / Munich, April 21, 2026 –– ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will provide quality of life data from its Phase 3 COMPETE trial in a poster presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting, held from May 29 - June 2, 2026 in Chicago, Illinois.
Global Virus Network on Measles ResurgenceRising cases in the U.S. and globally highlight gaps in vaccination coverage and growing vulnerabilities in public health systems
Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 TrialAs published in The Lancet and presented at AAN, NIMBLE trial met its primary and key secondary endpoints at week 24, demonstrating potential best-in-class efficacy and convenience in gMG
SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Super Micro Computer, Inc. (“Super Micro” or “the Company”) (
NASDAQ: SMCI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual MeetingHouston, Texas and Tuebingen, Germany, April 21, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced all submitted abstracts have been selected for oral presentations at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held from May 29-June 2, 2026, in Chicago, Illinois, USA.
IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ImmunityBio, Inc. (“ImmunityBio” or “the Company”) (
NASDAQ: IBRX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
DocHub Expands PDF Editing Capabilities With The New Edit Text FeatureBOSTON, April 21, 2026 (GLOBE NEWSWIRE) -- DocHub, an online platform for editing, signing, and sharing PDF documents, today announced the launch of a powerful new feature: Edit Text. This new tool addresses two of the most common frustrations in PDF workflows — making precise text edits and ensuring sensitive content is permanently removed.
NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026Poster to be presented at the American Society for Clinical Oncology on Monday, June 1, 2026
Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual MeetingDOYLESTOWN, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers, today announced the acceptance of an abstract “Early results from the first-in-human phase 1 study of WEE1 inhibitor APR-1051 in patients with advanced solid tumors (ACESOT-1051)” at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, to take place May 29 - June 2, 2026, in Chicago, IL.
Rails to Trails Conservancy Highlights Reasons to Get Outside This Spring with YourUpdateTVRails to Trails Conservancy marks 40 years of impact, calling on Americans to celebrate the impact trails make in our communities
Engine Technology Forum Webinar Clarifies Role of SCR and DEF Amid Recent EPA GuidanceWashington, DC, April 21, 2026 (GLOBE NEWSWIRE) -- The Engine Technology Forum (ETF) today announced the availability of the recorded version of its April 20 webinar, “Making Diesel Clean: What You Need to Know About SCR and DEF,” which brought together technical experts and industry leaders to explain the role of Selective Catalytic Reduction (SCR) and diesel exhaust fluid (DEF) in modern diesel engines and to address recent U.S. Environmental Protection Agency (EPA) guidance affecting these systems.
IP Strategy Announces Reverse Stock SplitGIG HARBOR, Wash., April 21, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST) (“IP Strategy” or the “Company”), the first company to adopt a treasury reserve policy centered on the $IP token, today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company’s common stock. The reverse stock split is expected to become effective at 12:01 a.m. on April 23, 2026, and the Company’s common stock is expected to begin trading on the Nasdaq Capital Market on a split-adjusted basis when the market opens on April 23, 2026 under its existing ticker symbol, “IPST.” The new CUSIP number will be 42727R 302.
COTY Investors Have Opportunity to Lead Coty Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Coty Inc. (“Coty” or “the Company”) (
NYSE: COTY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Record-Breaking Number of Candidates Sit for the CFP® ExamCFP Board Announces March 2026 CFP® Certification Exam Results
Forge Nano, U.S. Advanced Manufacturing Leader for AI-Era Chips and Defense Batteries, to List on NASDAQ through Merger with Archimedes Tech SPAC Partners II Co.DENVER and NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Forge Nano, Inc. (“Forge Nano” or the “Company”), a leading U.S. based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition (“ALD”) technology for artificial intelligence (“AI”)-era chip manufacturing and defense battery applications, and Archimedes Tech SPAC Partners II Co. (“Archimedes II”) (
NASDAQ: ATII), a publicly traded special purpose acquisition company, announced today that they have entered into a definitive business combination agreement (“Transaction”) that would result in Forge Nano becoming a publicly listed company. Upon closing of the Transaction, the combined company will operate as Forge Nano, Inc. and its common stock and warrants are expected to trade on NASDAQ under the new ticker symbol “NANO” and “NANOW” respectively. The Company will continue to be led by Forge Nano’s existing management team, which brings deep technological and manufacturing experience.
Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual MeetingWATERTOWN, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (
NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that it will present data from the RALLY-MF Phase 2 trial of DISC-0974 in anemia of myelofibrosis (MF) in an oral abstract session at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held in Chicago, IL on May 29-June 2, 2026.
Standard Premium to Present Strategic Priorities and Growth Trajectory at 2026 Annual Shareholders MeetingMIAMI, April 21, 2026 (GLOBE NEWSWIRE) -- Standard Premium Finance Holdings, Inc. (OTCQX: SPFX) (“Standard Premium”), a leading specialty finance company, today announces its Annual Shareholders Meeting on June 12, 2026 in Miami, FL. The meeting will update shareholders on Standard Premium’s compelling financial results, including 24% net income growth, an increase of 14% to the Company’s receivables portfolio and $158 million in loan originations. The meeting will also provide shareholders with the latest news on the Company’s growth trajectory, including ongoing initiatives to achieve licensing in all 50 states, a review of strategic goals implemented over the past year and opportunities for continued success that are critical to long-term value creation.
Panasonic Unveils New LUMIX S 40mm f/2 Lens for Everyday Shooting; More Info at B&HLearn more about Panasonic's latest lens, the LUMIX S 40mm f/2, an affordable, high-quality, normal-length prime lens optimized for hybrid creators.
Step Inside: Third Annual Living by Design Virtual Showhouse Now OpenThe showhouse returns for its third edition, spotlighting forward-thinking designs shaped by unrestricted creative exploration
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Atara Biotherapeutics, Inc. (“Atara” or “the Company”) (
NASDAQ: ATRA) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
NAR Pending Home Sales Report Shows 1.5% Increase in MarchWashington, D.C., April 21, 2026 (GLOBE NEWSWIRE) -- Pending home sales in March increased by 1.5% from the prior month and declined 1.1% year-over-year, according to the National Association of REALTORS® Pending Home Sales report. The report provides the real estate ecosystem—including agents, homebuyers and sellers—with data on the level of home sales under contract.
Bonaventure Closes on Royal Pointe Apartments in Virginia Beach, Expanding Multifamily Value-Add PortfolioALEXANDRIA, Va., April 21, 2026 (GLOBE NEWSWIRE) -- Bonaventure, an operator-led multifamily real estate investment firm with approximately $2.8 billion in assets under management (AUM), announced the closing of Royal Pointe Apartments, a 208-unit multifamily community in Virginia Beach, VA.
DLP Capital Appoints Eli Marshall to Lead Strategic Relationships and Organizational GrowthST. AUGUSTINE, Fla. and BETHLEHEM, Pa., April 21, 2026 (GLOBE NEWSWIRE) -- DLP Real Estate Capital, Inc. (DLP Capital), a private real estate investment firm with headquarters in St. Augustine, Florida, and offices in Bethlehem, Pennsylvania, and Asheville, North Carolina, announced today that Eli Marshall has joined DLP Capital as the firm’s President of Extraordinary Relationships and Organizations.
Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026BOSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc., a clinical-state biotechnology company pioneering condensate therapeutics, presented new preclinical data at the American Association for Cancer Research (AACR) Annual Meeting 2026 highlighting its approach to targeting MYC-driven cancers through biomolecular condensate modulation.
ACTG Launches Critical Study Evaluating Hormone Therapy for Women Living with HIV in the Menopause TransitionCHAPEL HILL, N.C., April 21, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of the HoT study (Menopausal Hormone Therapy for Women Living with HIV, also known as A5424), an essential new study with the potential to significantly expand the body of knowledge around menopause among women living with HIV. HoT is a phase 4, randomized, double-blind, placebo-controlled clinical trial that will evaluate the safety and efficacy of hormone therapy (estradiol gel with or without oral progesterone) compared to placebo for women living with HIV who are in the late menopausal transition or early post-menopause and experiencing moderate to severe vasomotor symptoms (commonly known as hot flashes and flushes and night sweats).
DISQO Names Terri Walter Chief Marketing OfficerIndustry Veteran Terri Walter Brings Two Decades of Ad Tech Brand Building and AI Expertise to DISQO’s Next Chapter Of Growth
SourceRE and Hive MLS Catch Major Vendors Circumventing MLS in Groundbreaking Forensic PilotForensic Pilot Reveals Widespread Data Violations Using SourceRE’s Proprietary Data Dye Technology
Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026To Highlight Efficacy Results from Relapsed or Refractory Waldenström Macroglobulinemia Patients Treated with Iopofosine I 131 Immediately Following BTK Inhibitor Therapy
Qualifacts Showcases AI Innovations, Interoperability, and Data Advancements at NatCon26Company to feature growing AI suite, including an enhanced iQ Agent for Scheduling and first look at iQ Agent for Billing and Reporting, at the behavioral health sector’s largest annual conference
Progress Software Releases 2025 Corporate Social Responsibility Report, Underscoring Global Commitment to Giving BackReport showcases a people‑first culture, measurable global community impact and continued advancements toward long‑term sustainability goals that contributed to multiple Best Workplace honors
TexBuy Purchasing Awards Gordian’s Job Order Contracts to Newly Selected Contractors Across TexasTexas agencies now have streamlined access to Gordian’s Job Order Contracting (JOC) solutions through newly awarded TexBuy contract #025-086.
LU Investors Have Opportunity to Lead Lufax Holding Ltd Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lufax Holding Ltd (“Lufax” or “the Company”) (
NYSE: LU) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination StrategiesNANJING, China, April 21, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the first patient has been successfully dosed in a phase Ⅱ clinical study evaluating Opamtistomig (LBL-024), the company’s core investigational PD-L1/4-1BB bispecific antibody, for the first-line treatment of locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.
CBS Sunday Morning Exposes Deadly Trucking Tragedy: Illegally-Operated Semitrailer Killed Entire Family on Christmas Eve Day, With A Non-English-Speaking Driver Hauling a C.H. Robinson LoadTOLEDO, Ohio, April 21, 2026 (GLOBE NEWSWIRE) -- CBS Sunday Morning reported on the deaths of five members of an Ohio family in a multi-vehicle truck crash on Christmas Eve in 2022. The Law Firm for Truck Safety, which represents the Boehne family and conducted an independent investigation of the crash, has filed suit against C.H. Robinson. The driver, who was hauling freight for C.H. Robinson and operating the semitrailer illegally, fled the country after the fatal crash.
HTGC Investors Have Opportunity to Lead Hercules Capital, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hercules Capital, Inc. (“Hercules” or “the Company”) (
NYSE: HTGC) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
PSIX Investors Have Opportunity to Lead Power Solutions International, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Power Solutions International, Inc. (“Power Solutions” or “the Company”) (
NASDAQ: PSIX) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
SpartanX Closes Seed Round Led by Venture Guides, Establishes Global Headquarters in Boston, and Appoints President and COO to Scale Go-to-Market OperationsBOSTON, April 21, 2026 (GLOBE NEWSWIRE) -- SpartanX, the AI-native offensive security company behind the industry's first fully autonomous full-stack red teaming platform, today announced the close of its seed round led by Venture Guides, with participation from additional angel and corporate investors. Alongside the funding, the company has established its new Global Headquarters in Boston and appointed a new President and Chief Operating Officer to lead the scaling of its sales, marketing, and customer success teams.
CIGL Investors Have Opportunity to Lead Concorde International Group Ltd. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Concorde International Group Ltd. (“Concorde” or “the Company”) (
NASDAQ: CIGL) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
